Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gilead Sciences

Clinical trials sponsored by Gilead Sciences, explained in plain language.

Gilead Sciences, Inc. GILD NASDAQ

A biopharmaceutical company developing antiviral and oncology drugs.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 25 Not yet recruiting 1 Not yet finished but already full! 43 Completed 12 Terminated 9

Can a new drug, GS-0415, help keep HIV in check? a First-in-Human trial aims to find out

Disease control Not yet recruiting

This early-stage trial is testing an experimental drug called GS-0415 in people with HIV who already have the virus well-controlled by standard antiretroviral therapy. The study will give single and multiple doses of GS-0415 to evaluate its safety, tolerability, and how the body …

Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC